| Symbol: |
TXLNG
|
| Description: |
taxilin gamma [Source:HGNC Symbol;Acc:18578]
|
| Location: |
ChrX:16804550-16862642[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:73
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| TXLNG |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.001 |
Down |
| TXLNG |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.034 |
Down |
| TXLNG |
AT 116, benzylamine salt |
0.022 |
Down |
| TXLNG |
Bromocriptine methanesulfonate |
0.038 |
Up |
| TXLNG |
Buclizine Hydrochloride |
0.027 |
Up |
| TXLNG |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.008 |
Down |
| TXLNG |
1H-Benz[g]indazole-3-carboxamide,1-(4-chlorophenyl)- N-[2-(diethylamino)ethyl]-4,5-dihydro-7-methoxy-, monohydrochloride |
0.027 |
Up |
| TXLNG |
NSC 303769 |
0.016 |
Up |
| TXLNG |
NSC 36758 |
0.009 |
Up |
| TXLNG |
NSC 41274 |
0.002 |
Up |
| TXLNG |
9,10-o-Benzenoanthracene-1,4-dione, 2,3-dichloro-9,10-dihydro- |
0.027 |
Down |
| TXLNG |
NSC 58903 |
0.041 |
Up |
| TXLNG |
NSC 611274 |
0.045 |
Up |
| TXLNG |
NSC 62349 |
0.037 |
Down |
| TXLNG |
L-Lysine, N-[(methylamino)carbonyl]-N'-(phenylmethoxy- carbonyl)-, phenylmethyl ester |
0.028 |
Up |
Expression pattern: Sensitivity / Resistance
Total:5 Current:1
[First] [Prev] Next Last
|
| SNP:
~ Export ~
|
Records:34
Total:3 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|